This article is more than 5 years old. Information may no longer be current.
Private ophthalmic companies showcase innovative new IOLs
Click Here to Manage Email Alerts
BOSTON — At the Ophthalmology Innovation Summit here, officials from several ophthalmic companies touted innovative new products currently under development.
Anew Optics is developing the Zephyr, an IOL design based on maintaining an open capsule and allowing circulation of the aqueous humor, according to CEO Anna Hayes.
The Zephyr is an 8.8-mm fully circular lens that keeps the capsule open and impedes lens epithelial migration, and the posterior ring keeps the optical zone clear, Hayes said.
Anna Hayes
“The anterior and posterior rings are essential,” she said. “You don’t need a square edge.”
The lens will start with a toric version, then go to pediatric and then accommodating, according to Hayes.
PowerVision has developed FluidVision, an accommodating IOL system based on fluid-controlled technology. The IOL responds to the natural muscular mechanics of the eye, with the fluid contained within the lens shifting with the eye, changing the shape and therefore the power of the lens as necessary.
“When the eye moves to its accommodative state, the capsular bag, which contains our lens, squeezes a little bit of fluid from the periphery of our lens into the middle,” Barry Cheskin, president and CEO of PowerVision, said. That inflates the lens and allows a patient to see up close. As the eye moves to a disaccommodative state, the reverse happens, allowing a patient to see far.
Barry Cheskin
The IOL is paired with a novel proprietary injector from PowerVision, the PowerJect, Cheskin said, which is a fluid-based method of delivering the lens, preloaded in the device, into the capsular bag with no change to the surgical procedure.
Disclosures: Cheskin is president and CEO of PowerVision. Hayes is CEO of Anew Optics.